×
0.0250421694563384 0.0185545607888932 -0.00739587388088755 -0.0592318671337744 -0.026858699883223 -0.0722719605553393 -0.0917347865576748 -0.0787595692227844
Stockreport

Capricor's DMD candidate nabs Rare Pediatric Disease Designation from FDA; shares ahead 115% [Seeking Alpha]

CAPRICOR THERAPEUTICS (CAPR)  More Company Research Source: Seeking Alpha
Last capricor therapeutics earnings: 8/9 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF Thinly traded nano cap Capricor Therapeutics ( CAPR ) rockets up on a whopping 60x surge in volume in response to the news that the FDA has granted Rare Pediatric Disease Designation to lead product candidate CAP-1002 for the treatment of Duchenne muscular dystrophy (DMD). The main benefit of the designation is the awarding of a Priority Review Voucher if the product is approved. The voucher can be used for accelerated review for a another product candidate or it can be sold to a third party. A registration study is on tap for H2. 12-month data from the Phase 1/2 HOPE study should be available in Q4. CAP-1002  is an investigational allogeneic, off-the-shelf cardiac cell therapy derived from donor heart tissue and infused directly into the patients coronary artery via a catheter. It is currently being evaluated for the treatment of heart disease associated with Duchenne muscular dystrophy and myocardial infarction (heart attack). Now read: 3 Things In Biotech Yo [Read more]

IMPACT SNAPSHOT EVENT TIME: CAPR
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
CAPR alerts

from News Quantified
Opt-in for
CAPR alerts

from News Quantified